Sung Hae Chang

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Interstitial Lung Disease

Systemic Sclerosis

Top Venues

Yonsei medical journal

Journal of Korean medical science

Rheumatology (Oxford, England)

BMC musculoskeletal disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Sung Hae Chang, Se Rim Choi, Yong Seok Choi, Dong Jin Go, Jun Won Park, You Jung Ha, Jin-Kyun Park, Eun Ha Kang, Eun Young Lee, Tae-Jong Kim, Eun Bong Lee, Yeong-Wook Song, Yun Jong Lee
Performance of cut-offs adjusted with positive control band intensity in line-blot assays for myositis-specific antibodies. Rheumatology international (2023)
Sang-Wan Chung, In Seol Yoo, Jinhyun Kim, Seong Wook Kang, Mi-Hye Kwon, Chung-Il Joung, In Ah Choi, Sung Hae Chang, Mi Il Kang, Seung Jae Hong, Yeon Ah Lee
Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients. Yonsei medical journal 62 (5) (2021)
Sung Hae Chang, Jae Bum Jun, Yun Jong Lee, Tae Young Kang, Ki Won Moon, Ji Hyeon Ju, Seong Wook Kang, In Ah Choi, Yong-Beom Park, Seung Geun Lee, Shin-Seok Lee, Nam Hun Heo, Eun Bong Lee
A clinical comparison of an endothelin receptor antagonist and phosphodiesterase type 5 inhibitors for treating digital ulcers of systemic sclerosis. Rheumatology (Oxford, England) 60 (12) (2021)
Jung Wan Park, Shi Nae Yu, Sung Hae Chang, Young Hyeon Ahn, Min Hyok Jeon
Multisystem Inflammatory Syndrome in an Adult after COVID-19 Vaccination: a Case Report and Literature Review. Journal of Korean medical science 36 (45) (2021)
Sung Won Lee, Seong-Yong Kim, Sung Hae Chang
Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study. BMC musculoskeletal disorders 20 (1) (2019)
Sung Hae Chang, Yun-Kyung Song, Seong-Su Nah
The Clinical Efficacy and Safety of Gumiganghwal-Tang in Knee Osteoarthritis: A Phase II Randomized Double Blind Placebo Controlled Study. Evidence-based complementary and alternative medicine : eCAM 2018 (2018)